Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist?
作者信息
Nebert D W
出版信息
Am J Hum Genet. 1997 Feb;60(2):265-71.
Abstract
摘要
相似文献
1
Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist?药物代谢酶中的多态性：其临床意义是什么，以及它们为何存在？
Am J Hum Genet. 1997 Feb;60(2):265-71.
2
Molecular mechanisms of genetic polymorphisms of drug metabolism.药物代谢遗传多态性的分子机制
Annu Rev Pharmacol Toxicol. 1997;37:269-96. doi: 10.1146/annurev.pharmtox.37.1.269.
3
[Genetic and phenotypic polymorphisms in carcinogen-metabolizing enzymes and cancer susceptibility].[致癌物代谢酶中的遗传和表型多态性与癌症易感性]
Nihon Rinsho. 1996 Aug;54(8):2261-75.
4
Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.人类药物代谢酶多态性：对毒性风险和癌症的影响。
DNA Cell Biol. 1996 Apr;15(4):273-80. doi: 10.1089/dna.1996.15.273.
5
The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of lung cancer: a meta-analysis.
Eur J Clin Pharmacol. 1997;51(5):389-93. doi: 10.1007/s002280050219.
6
Populations and genetic polymorphisms.
Mol Diagn. 1999 Dec;4(4):299-307. doi: 10.154/MODI00400299.
7
Expression in human prostate of drug- and carcinogen-metabolizing enzymes: association with prostate cancer risk.药物和致癌物代谢酶在人前列腺中的表达：与前列腺癌风险的关联。
Br J Cancer. 1998 Nov;78(10):1361-7. doi: 10.1038/bjc.1998.685.
8
Adverse drug reaction monitoring in Jena. Relevance of polymorphic drug metabolizing enzymes for inducing adverse drug reactions.耶拿的药物不良反应监测。多态性药物代谢酶在引发药物不良反应中的相关性。
Exp Toxicol Pathol. 2003 Jun;54(5-6):417-21. doi: 10.1078/0940-2993-00278.
9
Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects.长期给予双硫仑对健康人体受试者中CYP1A2、CYP2C19、CYP2D6、CYP2E1和N - 乙酰转移酶活性的影响。
Br J Clin Pharmacol. 2002 Feb;53(2):155-62. doi: 10.1046/j.1365-2125.2002.01522.x.
10
Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer.NAT2、CYP2D6、CYP2C19和GSTP1基因多态性及其与前列腺癌的关联。
Pharmacogenetics. 1999 Jun;9(3):333-40. doi: 10.1097/00008571-199906000-00008.
引用本文的文献
1
Ortholog genes from cactophilic Drosophila provide insight into human adaptation to hallucinogenic cacti.嗜仙人掌果蝇的同源基因为研究人类对致幻仙人掌的适应提供了线索。
Sci Rep. 2022 Aug 1;12(1):13180. doi: 10.1038/s41598-022-17118-x.
2
Pharmacogenetics and Forensic Toxicology: A New Step towards a Multidisciplinary Approach.药物遗传学与法医毒理学：迈向多学科方法的新步伐。
Toxics. 2021 Nov 4;9(11):292. doi: 10.3390/toxics9110292.
3
Gene-environment interactions between air pollution and biotransformation enzymes and risk of birth defects.空气污染与生物转化酶的基因-环境相互作用与出生缺陷风险。
Birth Defects Res. 2021 May 15;113(9):676-686. doi: 10.1002/bdr2.1880. Epub 2021 Feb 10.
4
The Metabolization Profile of the Gene in Amerindian Populations: A Review.《基因在美洲印第安人群体中的代谢谱：综述》。
Genes (Basel). 2020 Feb 28;11(3):262. doi: 10.3390/genes11030262.
5
The genetic and biochemical basis of trimethylaminuria in an Irish cohort.爱尔兰人群中三甲胺尿症的遗传和生化基础。
JIMD Rep. 2019 Mar 25;47(1):35-40. doi: 10.1002/jmd2.12028. eCollection 2019 May.
6
Genetic variation in biotransformation enzymes, air pollution exposures, and risk of spina bifida.生物转化酶的基因变异、空气污染暴露与脊柱裂风险
Am J Med Genet A. 2018 May;176(5):1055-1090. doi: 10.1002/ajmg.a.38661.
7
GSTT1, GSTP1, and GSTM1 genetic variants are associated with survival in previously untreated metastatic breast cancer.谷胱甘肽S-转移酶T1（GSTT1）、谷胱甘肽S-转移酶P1（GSTP1）和谷胱甘肽S-转移酶M1（GSTM1）基因变异与既往未经治疗的转移性乳腺癌患者的生存率相关。
Oncotarget. 2017 Nov 14;8(62):105905-105914. doi: 10.18632/oncotarget.22450. eCollection 2017 Dec 1.
8
Benefit of treatment of latent tuberculosis infection in individual patients.个体患者中潜伏性结核感染治疗的益处。
Eur Respir J. 2016 May;47(5):1592-4. doi: 10.1183/13993003.01946-2015.
9
Global genetic analyses reveal strong inter-ethnic variability in the loss of activity of the organic cation transporter OCT1.全球基因分析揭示了有机阳离子转运体OCT1活性丧失中强烈的种族间变异性。
Genome Med. 2015 Jun 18;7(1):56. doi: 10.1186/s13073-015-0172-0. eCollection 2015.
10
Suppression of CYP2C9 by microRNA hsa-miR-128-3p in human liver cells and association with hepatocellular carcinoma.微小RNA hsa-miR-128-3p在人肝细胞中对CYP2C9的抑制作用及其与肝细胞癌的关联
Sci Rep. 2015 Feb 23;5:8534. doi: 10.1038/srep08534.
本文引用的文献
1
Toxicity of angular furanocoumarins to swallowtail butterflies: escalation in a coevolutionary arms race?角呋喃香豆素对凤蝶的毒性：协同进化军备竞赛中的升级？
Science. 1981 May 22;212(4497):927-9. doi: 10.1126/science.212.4497.927.
2
Pinosylvin methyl ether deters snowshoe hare feeding on green alder.松柏苷甲醚可阻止雪兔取食绿桤木。
Science. 1983 Dec 2;222(4627):1023-5. doi: 10.1126/science.222.4627.1023.
3
Bark beetle conversion of a plant compound to a sex-specific inhibitor of pheromone attraction.树皮甲虫将植物化合物转化为性特异性信息素吸引力抑制剂。
Science. 1983 May 6;220(4597):624-6. doi: 10.1126/science.220.4597.624.
4
Evolution of diabroticite rootworm beetle (Chrysomelidae) receptors for Cucurbita blossom volatiles.瓜根萤叶甲（叶甲科）对南瓜花挥发物受体的进化
Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1869-72. doi: 10.1073/pnas.88.5.1869.
5
Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.高加索人群中的细胞色素P450 2D6变体：等位基因频率及表型后果
Am J Hum Genet. 1997 Feb;60(2):284-95.
6
Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk.吸烟、N-乙酰转移酶2基因多态性与乳腺癌风险。
JAMA. 1996 Nov 13;276(18):1494-501.
7
P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.细胞色素P450超家族：新序列、基因定位、登录号及命名法的更新
Pharmacogenetics. 1996 Feb;6(1):1-42. doi: 10.1097/00008571-199602000-00002.
8
Nomenclature for human CYP2D6 alleles.人类CYP2D6等位基因的命名法。
Pharmacogenetics. 1996 Jun;6(3):193-201. doi: 10.1097/00008571-199606000-00001.
9
Brain cannabinoids in chocolate.巧克力中的脑源性大麻素。
Nature. 1996 Aug 22;382(6593):677-8. doi: 10.1038/382677a0.
10
Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.人类药物代谢酶多态性：对毒性风险和癌症的影响。
DNA Cell Biol. 1996 Apr;15(4):273-80. doi: 10.1089/dna.1996.15.273.
Zotero 插件